Cleared Traditional

DR Safety Syringe, Sterile Hypodermic needle for Single use (K212226) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2021
Decision
75d
Days
Class 2
Risk

K212226 is an FDA 510(k) clearance for the DR Safety Syringe, Sterile Hypodermic needle for Single use. Classified as Syringe, Antistick (product code MEG), Class II - Special Controls.

Submitted by Zhuhai DR Medical Instruments Co., Ltd. (Zhuhai, CN). The FDA issued a Cleared decision on September 29, 2021 after a review of 75 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Zhuhai DR Medical Instruments Co., Ltd. devices

Submission Details

510(k) Number K212226 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 16, 2021
Decision Date September 29, 2021
Days to Decision 75 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 129d · This submission: 75d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code MEG Syringe, Antistick
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
Prithul Bom

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MEG Syringe, Antistick

All 38
Devices cleared under the same product code (MEG) and FDA review panel - the closest regulatory comparables to K212226.
Sterile Disposable Syringe with Saftey Needle, Sterile Disposable Syringe with Needle, Sterile Disposable Syringe, Sterile Disposable Safety Needle, Sterile Disposable Needle
K211329 · Jiangsu Kangbao Medical Equipment Co., Ltd. · Nov 2021
Hypodermic Safety Needle
K211555 · Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. · Oct 2021
Sterile Syringe With Safety Needle
K211753 · Jiangxi Hongda Medical Equipment Group , Ltd. · Oct 2021
Insulin Syringe, Insulin Syringe with Safety Retractable
K202570 · Jiangsu Micsafe Medical Technology Co., Ltd. · Jul 2021
TK Insulin Syringe with/without Saftey Retractable Device
K191639 · Anhui Tiankang Medical Technology Co., Ltd. · Sep 2020
1ml Luer Slip or Luer Lock Syringe, Syringe with permanently attached needle, Safety Syringe with permanently attached needle
K192551 · Jiangsu Caina Medical Co.,Ltd · Aug 2020

Related FDA 510(k) Regulatory Insights